Richard D. Francis, President and CEO at TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA), sold 47,546 shares at $15.91 ($751K) on 2025-03-05, disclosed to the SEC on 2025-03-06.
Scheduled sale ($751k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.73 | 15,514 | $244K | 32.5% |
| 2 | $15.73 | 15,514 | $244K | 32.5% |
| 3 | $15.91 | 8,259 | $131K | 17.5% |
| 4 | $15.91 | 8,259 | $131K | 17.5% |
| Total | $15.79 avg | 47,546 | $751K | 100% |
| Filing → |
| TEVA | SELL | 2026-03-06 | $1.5M | — | Filing → |
| TEVA | SELL | 2026-03-05 | $28.7M | — | Filing → |
| TEVA | SELL | 2026-02-18 | $30.6M | — | Filing → |